These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 25313766)

  • 1. Combination therapy increases the efficacy of docetaxel, vinblastine and tamoxifen in cancer cells.
    Samadi N; Ghanbari P; Mohseni M; Tabasinezhad M; Sharifi S; Nazemieh H; Rashidi MR
    J Cancer Res Ther; 2014; 10(3):715-21. PubMed ID: 25313766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of survivin restores the sensitivity of breast cancer cells to docetaxel and vinblastine.
    Ghanbari P; Mohseni M; Tabasinezhad M; Yousefi B; Saei AA; Sharifi S; Rashidi MR; Samadi N
    Appl Biochem Biotechnol; 2014 Sep; 174(2):667-81. PubMed ID: 25086926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil (VER) Enhances the Cytotoxic Effects of Docetaxel and Vinblastine Combined Therapy Against Non-Small Cell Lung Cancer Cell Lines.
    Jaferian S; Soleymaninejad M; Daraee H
    Drug Res (Stuttg); 2018 Mar; 68(3):146-152. PubMed ID: 29132176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway.
    Shaikh IA; Brown I; Schofield AC; Wahle KW; Heys SD
    Prostate; 2008 Nov; 68(15):1635-46. PubMed ID: 18668525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
    Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
    Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of combination treatment with gefitinib and docetaxel in EGFR-TKI-sensitive, primary resistant and acquired resistant human non-small cell lung cancer cells.
    Wu M; Yuan Y; Pan YY; Zhang Y
    Mol Med Rep; 2014 Jun; 9(6):2417-22. PubMed ID: 24682085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapeutic agents in gastric cancer cell lines.
    Bae SH; Ryoo HM; Kim MK; Lee KH; Sin JI; Hyun MS
    Oncol Rep; 2008 Apr; 19(4):1027-32. PubMed ID: 18357392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs.
    Frömberg A; Gutsch D; Schulze D; Vollbracht C; Weiss G; Czubayko F; Aigner A
    Cancer Chemother Pharmacol; 2011 May; 67(5):1157-66. PubMed ID: 20694726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy.
    Awasthi N; Schwarz MA; Schwarz RE
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):571-82. PubMed ID: 21110024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combined treatment with progesterone and tamoxifen on the growth and apoptosis of human ovarian cancer cells.
    Lee JY; Shin JY; Kim HS; Heo JI; Kho YJ; Kang HJ; Park SH; Lee JY
    Oncol Rep; 2012 Jan; 27(1):87-93. PubMed ID: 21922150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.
    Seitz S; Rick FG; Schally AV; Treszl A; Hohla F; Szalontay L; Zarandi M; Ortmann O; Engel JB; Buchholz S
    Oncol Rep; 2013 Jul; 30(1):413-8. PubMed ID: 23624870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in the balance of prosurvival and proapoptotic signalling pathways leads to sequence-dependent synergism between docetaxel and sorafenib in human non-small cell lung cancer cell lines.
    He X; Zhang T
    Cell Biochem Biophys; 2014 Mar; 68(2):411-8. PubMed ID: 23990130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signalling.
    Weigel MT; Meinhold-Heerlein I; Bauerschlag DO; Schem C; Bauer M; Jonat W; Maass N; Mundhenke C
    Cancer Lett; 2009 Jan; 273(1):70-9. PubMed ID: 18809244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo.
    Henry JY; Lu L; Adams M; Meyer B; Bartlett JB; Dalgleish AG; Galustian C
    Prostate; 2012 Jun; 72(8):856-67. PubMed ID: 21968939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis.
    Ferlini C; Scambia G; Distefano M; Filippini P; Isola G; Riva A; Bombardelli E; Fattorossi A; Benedetti Panici P; Mancuso S
    Br J Cancer; 1997; 75(6):884-91. PubMed ID: 9062411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schedule-dependent synergism and antagonism between pemetrexed and docetaxel in human lung cancer cell lines in vitro.
    Kano Y; Tanaka M; Akutsu M; Mori K; Yazawa Y; Mano H; Furukawa Y
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1129-37. PubMed ID: 19306094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer.
    Morgan C; Lewis PD; Jones RM; Bertelli G; Thomas GA; Leonard RC
    Acta Oncol; 2007; 46(5):669-77. PubMed ID: 17562444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
    Gewirtz DA; Di X; Walker TD; Sawyer ST
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can vitamin A modify the activity of docetaxel in MCF-7 breast cancer cells?
    Czeczuga-Semeniuk E; Lemancewicz D; Wolczyński S
    Folia Histochem Cytobiol; 2007; 45 Suppl 1():S169-74. PubMed ID: 18292828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells.
    Liu X; Wang J; Wang H; Liu S; Liang Y; Lv Z; Zhou Q; Ding W
    Oncol Rep; 2013 Oct; 30(4):1913-9. PubMed ID: 23912708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.